Grace Therapeutics, Inc. GRCE
NASDAQ · United States · Health Technology
$2.00-0.15 (-6.98%)
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market open· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
| Quarter | Report date | Actual EPS | Estimated EPS | EPS surprise | Actual revenue | Revenue surprise | Price reaction |
|---|---|---|---|---|---|---|---|
| Q1 2026 | 2026-08-13 | -0.91 | -0.13 | -603.8% | $0 | — | +2.9%$2.10→$2.16 |
| Q4 2026 | 2026-06-18 | -0.08 | -0.20 | +60.0% | — | — | +1.8%$2.22→$2.26 |
| Q4 2025 | 2026-02-12 | -0.14 | -0.09 | -55.6% | — | — | +0.6%$3.59→$3.61 |
| Q3 2025 | 2025-11-13 | -0.15 | -0.12 | -25.0% | — | — | +1.0%$3.03→$3.06 |
| Q4 2025 | 2025-06-23 | 0.14 | -0.40 | +135.0% | — | — | — |
| Q1 2025 | 2024-08-09 | -0.33 | -0.36 | +8.3% | — | — | — |
| Q4 2024 | 2024-06-21 | -0.36 | -0.47 | +23.4% | — | — | — |
| Q3 2024 | 2024-02-12 | -0.28 | -0.31 | +9.7% | — | — | — |
The price reaction is the change from the last close before the announcement date to the first close after it - the report may land before the open, during the session or after the close, so this window covers all three. Not investment advice.